196 related articles for article (PubMed ID: 2476814)
61. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells.
Martinand C; Montavon C; Salehzada T; Silhol M; Lebleu B; Bisbal C
J Virol; 1999 Jan; 73(1):290-6. PubMed ID: 9847332
[TBL] [Abstract][Full Text] [Related]
62. Biologically stable 2-5A analogues containing 3'-O,4'-C-bridged adenosine as potent RNase L agonists.
Morita K; Kaneko M; Obika S; Imanishi T; Kitade Y; Koizumi M
ChemMedChem; 2007 Dec; 2(12):1703-7. PubMed ID: 17910011
[No Abstract] [Full Text] [Related]
63. Short, terminally phosphorylated oligoriboguanylic acids effectively inhibit cytopathicity caused by human immunodeficiency virus.
Fujihashi T; Sakata T; Kaji A; Kaji H
Biochem Biophys Res Commun; 1994 Sep; 203(2):1244-50. PubMed ID: 7916572
[TBL] [Abstract][Full Text] [Related]
64. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
[TBL] [Abstract][Full Text] [Related]
65. Dissection of the roles of adenine ring nitrogen (N-1) and exocyclic amino (N-6) moieties in the interaction of 2-5A with RNase L.
Player MR; Kalinichenko EN; Podkopaeva TL; Mikhailopulo IA; Seela F; Torrence PF
Biochem Biophys Res Commun; 1998 Apr; 245(2):430-4. PubMed ID: 9571169
[TBL] [Abstract][Full Text] [Related]
66. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
[TBL] [Abstract][Full Text] [Related]
67. Template. Phosphorothioate oligonucleotides duplexes as inhibitors of HIV-1 reverse transcriptase.
Maury G; el Alaoui A; Morvan F; Müller B; Imbach JL; Goody RS
Biochem Biophys Res Commun; 1992 Aug; 186(3):1249-56. PubMed ID: 1380799
[TBL] [Abstract][Full Text] [Related]
68. Activation of 2-5A-dependent RNase by analogs of 2-5A (5'-O-triphosphoryladenylyl(2'----5')adenylyl(2'----5')adenosine ) using 2',5'-tetraadenylate (core)-cellulose.
Krause D; Lesiak K; Imai J; Sawai H; Torrence PF; Silverman RH
J Biol Chem; 1986 May; 261(15):6836-9. PubMed ID: 3700418
[TBL] [Abstract][Full Text] [Related]
69. Phosphorodithioate DNA as a potential therapeutic drug.
Marshall WS; Caruthers MH
Science; 1993 Mar; 259(5101):1564-70. PubMed ID: 7681216
[TBL] [Abstract][Full Text] [Related]
70. Synthesis of 2'-end-modified 2'-5'-oligoadenylates.
Hayakawa Y; Nobori T; Noyori R
Nucleic Acids Symp Ser; 1985; (16):129-32. PubMed ID: 4088856
[TBL] [Abstract][Full Text] [Related]
71. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
[TBL] [Abstract][Full Text] [Related]
72. The synthesis of nucleoside 5'-O-(1,1-dithiotriphosphates).
Okruszek A; Olesiak M; Balzarini J
J Med Chem; 1994 Oct; 37(22):3850-4. PubMed ID: 7525960
[TBL] [Abstract][Full Text] [Related]
73. Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells.
Bayard B; Bisbal C; Lebleu B
Biochemistry; 1986 Jun; 25(12):3730-6. PubMed ID: 3013297
[TBL] [Abstract][Full Text] [Related]
74. 8-Methyladenosine-substituted analogues of 2-5A: synthesis and their biological activities.
Kitade Y; Nakata Y; Hirota K; Maki Y; Pabuccuoglu A; Torrence PF
Nucleic Acids Res; 1991 Aug; 19(15):4103-8. PubMed ID: 1714563
[TBL] [Abstract][Full Text] [Related]
75. An unusual "senseless" 2',5'-oligoribonucleotide with potent anti-HIV activity.
Aboul-Fadl T; Agrawal VK; Buckheit RW; Broom AD
Nucleosides Nucleotides Nucleic Acids; 2004; 23(3):545-54. PubMed ID: 15113022
[TBL] [Abstract][Full Text] [Related]
76. Properties of quadruplex oligonucleotides with anti-HIV-1 activity.
Tamura Y; Yoshida M; Suzuki J; Hiratou T; Miyano-Kurosaki N; Takai K; Takaku H
Nucleic Acids Symp Ser; 2000; (44):181-2. PubMed ID: 12903328
[TBL] [Abstract][Full Text] [Related]
77. Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.
Lee DS; Jung KE; Yoon CH; Lim H; Bae YS
Antimicrob Agents Chemother; 2005 Oct; 49(10):4110-20. PubMed ID: 16189087
[TBL] [Abstract][Full Text] [Related]
78. Synthesis and biological activities of 8-substituted 2-5A analogues.
Nagai K; Yokoyama S; Kawai G; Shuhadlnik RJ; Takaku H
Nucleic Acids Symp Ser; 1990; (22):13-4. PubMed ID: 2101896
[TBL] [Abstract][Full Text] [Related]
79. Inhibition of growth of estrogen receptor positive and estrogen receptor negative breast cancer cells in culture by AA-etherA, a stable 2-5A derivative.
Latham KE; Cosenza S; Reichenbach NL; Mordechai E; Adelson ME; Kon N; Horvath SE; Charubala R; Mikhailov SN; Pfeiderer W; Suhadolnik RJ
Oncogene; 1996 Feb; 12(4):827-37. PubMed ID: 8632905
[TBL] [Abstract][Full Text] [Related]
80. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
